Literature DB >> 2849638

Vector competence of Aedes albopictus from Houston, Texas, for dengue serotypes 1 to 4, yellow fever and Ross River viruses.

C J Mitchell1, B R Miller, D J Gubler.   

Abstract

A combination of virus infection and transmission experiments showed that a Houston, Texas strain of Aedes albopictus is a competent vector for dengue (DEN), yellow fever (YF) and Ross River (RR) viruses. However, at 14 days incubation, DEN virus infection rates in a Puerto Rican strain of Aedes aegypti were significantly higher for each of the four DEN serotypes, except DEN-1, than in Houston Ae. albopictus fed simultaneously on the same virus suspensions. The degree of correlation between disseminated DEN infection rates in Houston Ae. albopictus and transmission to an in vitro system ranged from 42 to 88% for the four DEN serotypes. No significant difference was noted in YF virus infection rates or transmission rates in the two mosquito species fed on the same virus suspensions and incubated for the same time period. Also, RR virus infection and transmission rates in Houston and Hawaiian strains of Ae. albopictus were generally comparable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2849638

Source DB:  PubMed          Journal:  J Am Mosq Control Assoc        ISSN: 8756-971X            Impact factor:   0.917


  14 in total

1.  Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; Nancy Gallagher; Nina Marano; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus.

Authors:  Juliet E Bryant; Pedro F C Vasconcelos; Rene C A Rijnbrand; J P Mutebi; Stephen Higgs; Alan D T Barrett
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Ross River virus transmission, infection, and disease: a cross-disciplinary review.

Authors:  D Harley; A Sleigh; S Ritchie
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 4.  Aedes aegypti vector competence studies: A review.

Authors:  Jayme A Souza-Neto; Jeffrey R Powell; Mariangela Bonizzoni
Journal:  Infect Genet Evol       Date:  2018-11-19       Impact factor: 3.342

Review 5.  Potential changes in disease patterns and pharmaceutical use in response to climate change.

Authors:  Clare H Redshaw; Will M Stahl-Timmins; Lora E Fleming; Iain Davidson; Michael H Depledge
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

6.  Updating the geographical distribution and frequency of Aedes albopictus in Brazil with remarks regarding its range in the Americas.

Authors:  Roberta Gomes Carvalho; Ricardo Lourenço-de-Oliveira; Ima Aparecida Braga
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-09       Impact factor: 2.743

Review 7.  Ten years of the Tiger: Aedes albopictus presence in Australia since its discovery in the Torres Strait in 2005.

Authors:  Andrew F van den Hurk; Jay Nicholson; Nigel W Beebe; Joe Davis; Odwell M Muzari; Richard C Russell; Gregor J Devine; Scott A Ritchie
Journal:  One Health       Date:  2016-02-24

8.  Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.

Authors:  Konstantin A Tsetsarkin; Charles E McGee; Sara M Volk; Dana L Vanlandingham; Scott C Weaver; Stephen Higgs
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

Review 9.  Nature, nurture and evolution of intra-species variation in mosquito arbovirus transmission competence.

Authors:  Walter J Tabachnick
Journal:  Int J Environ Res Public Health       Date:  2013-01-11       Impact factor: 3.390

10.  Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus.

Authors:  Kathryn A Hanley; Jacob T Nelson; Erin E Schirtzinger; Stephen S Whitehead; Christopher T Hanson
Journal:  BMC Ecol       Date:  2008-02-13       Impact factor: 2.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.